[HT-11-2] 腸内細菌バイオカーカー
Biomarkers related to the diagnosis and progression of Parkinson's disease are significant for early diagnosis including prodromal stage, prognosis, and development of novel therapies. Even now, there are excellent biomarkers, and although diagnostic criteria for the prodromal stage have been proposed, improvement in diagnostic sensitivity and specificity is inevitable. Based on such a background, recent advances in visualization technology using MRI and nuclear medicine, a more in-depth understanding of the effects of gut microbiota on the pathology, advances in blood biomarker measurement technology such as α-synuclein, and skin pathology are something amazing. In this session, symposists who are specialists in each field will provide the latest information and knowledge. We hope young researchers will envision the direction and potential of future research and encourage their research minds.
1984 Graduated from Graduate School of Medicine, Gifu University
1984 Rotate training at Nagoya University Graduate School of Medicine
1988 Doctor of Neurology, Okazaki Municipal Hospital
1989, Nagoya University Hospital, Department of Neurology
1993 Nagoya Quarantine Station Quarantine Division Quarantine Division Manager
1996 Assistant Professor, Department of Neurophysiology, Laboratory, Nagoya University Hospital
2007 Lecturer, Department of Neurophysiology, Laboratory, Nagoya University Hospital, Deputy Director
2010 Associate Professor Graduate School of Medicine, Nagoya University Department of Medical Technology Associate Professor
Councilor
Councilor of Japan Society of Neurovegetative Research
Councilor of the Japanese Society of Neurology
Councilor of the Japanese Peripheral Nerve society
抄録パスワード認証
パスワードは抄録集に記載してあります。